Clinical Trials Browser

Phase 2 × Advanced Primary Liver Cancer × camrelizumab × Clear all

NCT03092895 2026-01-29

A Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC

Phase 2 Completed

157 enrolled 17 charts

Gastrointestinal

Advanced Primary Liver Cancer